PROCYTE
Live / Allowed — Notice of allowance issued (as of 06 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99020991
- Mark type
- Stylized text
- Filed
- 28 Jan 2025
- Published for opposition
- 11 Nov 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Stem cells for research or scientific purposes
- Class 005 — Pharmaceuticals: Bio-engineered cells for medical use; preparations of cells, namely, induced pluripotent stem cells (iPSCs), hepatocytes, induced pluripotent stem cell (iPSC)-derived hepatocytes, hepatocyte-like cells, adipose cells, and adipogenic cells in the field of cellular medicine for the treatment of genetic diseases and disorders, genomic diseases and disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; pharmaceutical and therapeutic preparations for the treatment of diseases, namely, genetic diseases and disorders, genomic diseases and disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; implantable therapeutics, namely, DNA vectors being molecules for delivering genetic material into cells and cells used for human gene therapy for medical use
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; stem cell research services; technical scientific consultation and product development for others in the field of biotechnology, bioengineering, and the development of pharmaceuticals; pharmaceutical drug development services
Owner
- Flagship Labs 68, Inc., Cambridge, MA, US
- Flagship Labs 68, Inc., Cambridge, MA, US
Prosecution history
- 06 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Nov 2025 — PUBLISHED FOR OPPOSITION
- 05 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Jul 2025 — NON-FINAL ACTION E-MAILED
- 15 Jul 2025 — NON-FINAL ACTION WRITTEN
- 09 Jul 2025 — ASSIGNED TO EXAMINER
- 30 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Jan 2025 — APPLICATION FILING RECEIPT MAILED
- 28 Jan 2025 — NEW APPLICATION ENTERED